Features
News roundups
Announcements
Most Viewed      Most Discussed

A filing in a Massachusetts lawsuit contains dozens of internal Purdue Pharma documents suggesting the family was far more involved than the company has long contended

Quick Read

More than half of older Americans lack the skills to gather and understand medical information. Providers must simplify, researchers say

Quick Read

“A lot of women don’t understand just how poor the evidence base is,” said Carleigh Krubiner, PhD, a research scholar at the Johns Hopkins Berman Institute of Ethics. “It really is shocking when you think about how poorly the research enterprise has done.”

Quick Read

Then opioid prescribing dropped. In a small, randomized trial, researchers showed that this intervention — aimed at making the abstract issue of safe prescribing individually tangible — led to a slight reduction in the amount of opioids these clinicians prescribed

Quick Read

We often prescribe new medications that were proven to be effective in rigorous clinical trials and were approved by the Food and Drug Adminstration only to find that our patients don’t get better

Quick Read

Ketamine is one step closer to becoming mainstream medicine, thanks to the results of a Phase II clinical trial. But some experts are wary of creating a new drug-abuse crisis by introducing a potentially addictive drug to millions of new users

Quick Read

Mr. Jones enters the pharmacy expecting to pick up his prescription. But when he gets to the window, he gets a rude awakening. His acne cream is $200, much too expensive for him to afford. What can doctors do about it?

Quick Read

Gale Dunham, a pharmacist in Calistoga, Calif., knows the devastation the opioid epidemic has wrought, and she is glad the anti-overdose drug naloxone is becoming more accessible. But so far, Dunham said, she has not taken advantage of a California law that allows pharmacists to dispense the medication to patients without a doctor’s prescription

Quick Read